A389470 Stock Overview
Inventage Lab Inc., a platform technology company, develops medicines using microfluidics based drug delivery systems.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Inventage Lab, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩10,290.00 |
| 52 Week High | ₩32,750.00 |
| 52 Week Low | ₩8,800.00 |
| Beta | 0 |
| 11 Month Change | 4.79% |
| 3 Month Change | -15.86% |
| 1 Year Change | 9.94% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| A389470 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 5.5% | -0.4% | 0.6% |
| 1Y | 9.9% | 15.4% | 6.5% |
Return vs Industry: A389470 underperformed the KR Biotechs industry which returned 15.4% over the past year.
Return vs Market: A389470 exceeded the KR Market which returned 6.5% over the past year.
Price Volatility
| A389470 volatility | |
|---|---|
| A389470 Average Weekly Movement | 9.3% |
| Biotechs Industry Average Movement | 7.4% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.2% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A389470's share price has been volatile over the past 3 months.
Volatility Over Time: A389470's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Juhee Kim | www.inventagelab.com |
Inventage Lab Inc., a platform technology company, develops medicines using microfluidics based drug delivery systems. The company was founded in 2015 and is based in Seongnam-si, South Korea.
Inventage Lab, Inc. Fundamentals Summary
| A389470 fundamental statistics | |
|---|---|
| Market cap | ₩86.99b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A389470 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A389470 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A389470 perform over the long term?
See historical performance and comparison